Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 2 | 580 | 220 | 550 |
| Marketable Securities | N/A | 0 | 1,000 | 0 | 0 |
| Receivables | N/A | 0 | 0 | 70 | 150 |
| Other current assets | 0 | 0 | 20 | 30 | 40 |
| TOTAL | $1 | $2 | $1,600 | $320 | $740 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 0 | 3 | 10 |
| Other Non-Current Assets | 0 | 0 | 0 | 130 | 130 |
| TOTAL | $N/A | $N/A | $N/A | $133 | $140 |
| Total Assets | $1 | $2 | $1,600 | $460 | $890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11 | 10 | 1 | 30 | 10 |
| Accrued Expenses | N/A | 0 | 30 | 40 | 150 |
| TOTAL | $51 | $10 | $40 | $80 | $170 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $51 | $10 | $40 | $80 | $170 |
| Shareholders' Equity | |||||
| Common Shares | 65 | 650 | 650 | 470 | 470 |
| Retained earnings | -47,334 | -47,290 | -45,720 | -46,530 | -46,180 |
| Other shareholders' equity | 0 | 0 | -10 | -10 | -10 |
| TOTAL | $-50 | $-10 | $1,550 | $370 | $710 |
| Total Liabilities And Equity | $1 | $0 | $1,590 | $450 | $880 |